SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-022919
Filing Date
2024-07-17
Accepted
2024-07-17 16:23:35
Documents
16
Period of Report
2024-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240717_8k.htm   iXBRL 8-K 34791
2 EXHIBIT 99.1 ex_699299.htm EX-99.1 9514
7 ex_699299img001.jpg GRAPHIC 3748
  Complete submission text file 0001437749-24-022919.txt   187785

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20240717.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240717_def.xml EX-101.DEF 11421
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240717_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240717_pre.xml EX-101.PRE 11581
18 EXTRACTED XBRL INSTANCE DOCUMENT opk20240717_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 241122514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)